Go Pro

Cellebrite DI (CLBT) Competitors

Cellebrite DI logo
$16.45 +0.80 (+5.14%)
As of 12:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CLBT vs. NTNX, PTC, DT, AUR, and U

Should you buy Cellebrite DI stock or one of its competitors? MarketBeat compares Cellebrite DI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cellebrite DI include Nutanix (NTNX), PTC (PTC), Dynatrace (DT), Aurora Innovation (AUR), and Unity Software (U). These companies are all part of the "computer software" industry.

How does Cellebrite DI compare to Nutanix?

Nutanix (NASDAQ:NTNX) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

85.3% of Nutanix shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 2.4% of Nutanix shares are owned by company insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Nutanix has higher revenue and earnings than Cellebrite DI. Nutanix is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutanix$2.54B5.62$188.37M$0.9555.51
Cellebrite DI$475.67M8.62$78.33M$0.2858.73

In the previous week, Nutanix had 2 more articles in the media than Cellebrite DI. MarketBeat recorded 2 mentions for Nutanix and 0 mentions for Cellebrite DI. Nutanix's average media sentiment score of 0.00 equaled Cellebrite DI'saverage media sentiment score.

Company Overall Sentiment
Nutanix Neutral
Cellebrite DI Neutral

Cellebrite DI has a net margin of 14.48% compared to Nutanix's net margin of 10.03%. Cellebrite DI's return on equity of 18.38% beat Nutanix's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutanix10.03% -38.96% 8.55%
Cellebrite DI 14.48%18.38%9.68%

Nutanix presently has a consensus target price of $60.00, indicating a potential upside of 13.77%. Cellebrite DI has a consensus target price of $21.40, indicating a potential upside of 30.15%. Given Cellebrite DI's stronger consensus rating and higher probable upside, analysts plainly believe Cellebrite DI is more favorable than Nutanix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutanix
0 Sell rating(s)
8 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.56
Cellebrite DI
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Nutanix has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

Summary

Cellebrite DI beats Nutanix on 9 of the 15 factors compared between the two stocks.

How does Cellebrite DI compare to PTC?

PTC (NASDAQ:PTC) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

PTC has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

PTC has a net margin of 41.81% compared to Cellebrite DI's net margin of 14.48%. PTC's return on equity of 25.84% beat Cellebrite DI's return on equity.

Company Net Margins Return on Equity Return on Assets
PTC41.81% 25.84% 15.06%
Cellebrite DI 14.48%18.38%9.68%

PTC has higher revenue and earnings than Cellebrite DI. PTC is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PTC$2.74B5.29$734M$10.4811.97
Cellebrite DI$475.67M8.62$78.33M$0.2858.73

In the previous week, PTC had 13 more articles in the media than Cellebrite DI. MarketBeat recorded 13 mentions for PTC and 0 mentions for Cellebrite DI. PTC's average media sentiment score of 0.98 beat Cellebrite DI's score of 0.00 indicating that PTC is being referred to more favorably in the media.

Company Overall Sentiment
PTC Positive
Cellebrite DI Neutral

95.1% of PTC shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 0.3% of PTC shares are owned by company insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

PTC presently has a consensus target price of $173.60, indicating a potential upside of 38.34%. Cellebrite DI has a consensus target price of $21.40, indicating a potential upside of 30.15%. Given PTC's higher possible upside, equities research analysts plainly believe PTC is more favorable than Cellebrite DI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PTC
1 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.53
Cellebrite DI
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

PTC beats Cellebrite DI on 11 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Dynatrace?

Dynatrace (NYSE:DT) and Cellebrite DI (NASDAQ:CLBT) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

94.3% of Dynatrace shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 0.6% of Dynatrace shares are owned by company insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cellebrite DI has a net margin of 14.48% compared to Dynatrace's net margin of 8.06%. Cellebrite DI's return on equity of 18.38% beat Dynatrace's return on equity.

Company Net Margins Return on Equity Return on Assets
Dynatrace8.06% 10.37% 6.74%
Cellebrite DI 14.48%18.38%9.68%

Dynatrace has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market.

In the previous week, Dynatrace had 4 more articles in the media than Cellebrite DI. MarketBeat recorded 4 mentions for Dynatrace and 0 mentions for Cellebrite DI. Dynatrace's average media sentiment score of 0.38 beat Cellebrite DI's score of 0.00 indicating that Dynatrace is being referred to more favorably in the media.

Company Overall Sentiment
Dynatrace Neutral
Cellebrite DI Neutral

Dynatrace has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than Dynatrace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dynatrace$2.02B6.60$162.67M$0.5484.67
Cellebrite DI$475.67M8.62$78.33M$0.2858.73

Dynatrace presently has a consensus target price of $47.88, indicating a potential upside of 4.73%. Cellebrite DI has a consensus target price of $21.40, indicating a potential upside of 30.15%. Given Cellebrite DI's stronger consensus rating and higher probable upside, analysts clearly believe Cellebrite DI is more favorable than Dynatrace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatrace
1 Sell rating(s)
6 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.72
Cellebrite DI
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

Dynatrace and Cellebrite DI tied by winning 8 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Aurora Innovation?

Aurora Innovation (NASDAQ:AUR) and Cellebrite DI (NASDAQ:CLBT) are both computer software companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

Aurora Innovation presently has a consensus target price of $12.25, indicating a potential upside of 77.66%. Cellebrite DI has a consensus target price of $21.40, indicating a potential upside of 30.15%. Given Aurora Innovation's higher probable upside, equities analysts clearly believe Aurora Innovation is more favorable than Cellebrite DI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Innovation
2 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.45
Cellebrite DI
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

44.7% of Aurora Innovation shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 8.5% of Aurora Innovation shares are owned by insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Aurora Innovation had 3 more articles in the media than Cellebrite DI. MarketBeat recorded 3 mentions for Aurora Innovation and 0 mentions for Cellebrite DI. Aurora Innovation's average media sentiment score of 1.13 beat Cellebrite DI's score of 0.00 indicating that Aurora Innovation is being referred to more favorably in the media.

Company Overall Sentiment
Aurora Innovation Positive
Cellebrite DI Neutral

Cellebrite DI has a net margin of 14.48% compared to Aurora Innovation's net margin of -20,775.00%. Cellebrite DI's return on equity of 18.38% beat Aurora Innovation's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Innovation-20,775.00% -40.45% -36.66%
Cellebrite DI 14.48%18.38%9.68%

Aurora Innovation has a beta of 2.63, meaning that its stock price is 163% more volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market.

Cellebrite DI has higher revenue and earnings than Aurora Innovation. Aurora Innovation is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Innovation$3M4,507.49-$816M-$0.44N/A
Cellebrite DI$475.67M8.62$78.33M$0.2858.73

Summary

Cellebrite DI beats Aurora Innovation on 9 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Unity Software?

Cellebrite DI (NASDAQ:CLBT) and Unity Software (NYSE:U) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 73.5% of Unity Software shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by insiders. Comparatively, 0.8% of Unity Software shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cellebrite DI has a net margin of 14.48% compared to Unity Software's net margin of -34.99%. Cellebrite DI's return on equity of 18.38% beat Unity Software's return on equity.

Company Net Margins Return on Equity Return on Assets
Cellebrite DI14.48% 18.38% 9.68%
Unity Software -34.99%-1.30%-0.61%

Cellebrite DI has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, Unity Software has a beta of 2.05, suggesting that its stock price is 105% more volatile than the broader market.

Cellebrite DI currently has a consensus target price of $21.40, indicating a potential upside of 30.15%. Unity Software has a consensus target price of $37.71, indicating a potential upside of 26.38%. Given Cellebrite DI's stronger consensus rating and higher possible upside, equities analysts clearly believe Cellebrite DI is more favorable than Unity Software.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cellebrite DI
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Unity Software
1 Sell rating(s)
9 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.57

Cellebrite DI has higher earnings, but lower revenue than Unity Software. Unity Software is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cellebrite DI$475.67M8.62$78.33M$0.2858.73
Unity Software$1.92B6.77-$402.77M-$1.57N/A

In the previous week, Unity Software had 9 more articles in the media than Cellebrite DI. MarketBeat recorded 9 mentions for Unity Software and 0 mentions for Cellebrite DI. Unity Software's average media sentiment score of 0.91 beat Cellebrite DI's score of 0.00 indicating that Unity Software is being referred to more favorably in the news media.

Company Overall Sentiment
Cellebrite DI Neutral
Unity Software Positive

Summary

Cellebrite DI beats Unity Software on 10 of the 17 factors compared between the two stocks.

Get Cellebrite DI News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLBT vs. The Competition

MetricCellebrite DIINTERNET SOFTWARE IndustryComputer SectorNASDAQ Exchange
Market Cap$4.11B$17.24B$38.99B$12.63B
Dividend YieldN/A3.50%3.19%6.52%
P/E Ratio58.8167.81170.9024.91
Price / Sales8.6240.55596.6883.19
Price / Cash38.7376.1945.6449.23
Price / Book8.146.989.786.56
Net Income$78.33M$385.08M$1.07B$336.03M
7 Day Performance16.04%22.59%3.50%2.91%
1 Month Performance19.15%5.07%1.56%5.78%
1 Year Performance7.44%-6.06%145.92%25.83%

Cellebrite DI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLBT
Cellebrite DI
3.8437 of 5 stars
$16.44
+5.1%
$21.40
+30.1%
+2.2%$4.11B$475.67M58.811,285
NTNX
Nutanix
2.7629 of 5 stars
$51.06
+2.7%
$60.00
+17.5%
-33.2%$13.44B$2.54B53.757,800
PTC
PTC
4.6563 of 5 stars
$113.89
-1.6%
$173.60
+52.4%
-28.9%$13.37B$2.74B10.877,642
DT
Dynatrace
3.2183 of 5 stars
$44.21
+1.9%
$47.88
+8.3%
-21.0%$12.64B$2.02B81.875,600
AUR
Aurora Innovation
3.7474 of 5 stars
$6.62
+4.1%
$12.25
+85.0%
+25.4%$12.47B$3MN/A1,900

Related Companies and Tools


This page (NASDAQ:CLBT) was last updated on 7/6/2026 by MarketBeat.com Staff.
From Our Partners